Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Vet Comp Oncol ; 16(1): 90-101, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28643878

RESUMEN

We evaluated stereotactic volume modulated arc radiotherapy (VMAT) for canine gliomas, alone (radiotherapy [RT]) and in combination with temozolomide (RT + TMZ), compared with palliation. Overall and disease-specific survival times were estimated. Thirty dogs were palliated, 22 dogs were treated with RT and 20 with RT + TMZ. Complete and partial responses were observed in 63.2% and 90.9% of patients in the RT and RT + TMZ arms, respectively, that were alive at 1 year. Median survival in the palliation arm was 94 days (95% conformity index [CI] 87÷101). Median survivals of the RT arm (383 days, 95% CI 276÷490) and RT+TMZ arm (420 days, 95% CI 280÷560) were not significantly different (P = .61). Positive correlation with survival was found both for the ratio between target and brain (relative) volume of the tumour of <5% (P = .013) and for a clinical presentation with normal mentation (P = .032). VMAT is feasible and effective for canine brain gliomas. Combining this therapy with TMZ did not elicit any additional improvement in survival time.


Asunto(s)
Antineoplásicos Alquilantes/uso terapéutico , Neoplasias Encefálicas/veterinaria , Dacarbazina/análogos & derivados , Enfermedades de los Perros/radioterapia , Glioma/veterinaria , Radiocirugia/veterinaria , Animales , Neoplasias Encefálicas/tratamiento farmacológico , Neoplasias Encefálicas/radioterapia , Neoplasias Encefálicas/terapia , Terapia Combinada/veterinaria , Dacarbazina/uso terapéutico , Enfermedades de los Perros/tratamiento farmacológico , Enfermedades de los Perros/mortalidad , Enfermedades de los Perros/terapia , Perros , Femenino , Glioma/tratamiento farmacológico , Glioma/radioterapia , Glioma/terapia , Masculino , Radiocirugia/métodos , Análisis de Supervivencia , Temozolomida
2.
J Small Anim Pract ; 57(12): 710-717, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27759159

RESUMEN

OBJECTIVES: To evaluate the feasibility and efficacy of hypofractionated stereotactic volumetric-modulated arc radiotherapy in treating canine adrenal tumours with vascular invasion. METHODS: A single-arm clinical study was performed. The dogs underwent total body computed tomography, brain and abdomen magnetic resonance imaging and endocrine assay. Adrenal masses were classified as cortisol-secreting adrenal tumour or non-secreting adrenal tumour. Radiotherapy treatments were delivered by hypofractionated stereotactic volumetric-modulated arc radiotherapy via a linear accelerator. The overall survival was estimated by the Kaplan-Meier method. The overall response and radio-toxicity effects were determined. RESULTS: Nine dogs were enrolled. Three dogs were affected by cortisol-secreting adrenal tumours and the remaining dogs had non-secreting adrenal tumours. The prescribed doses ranged from 30 to 45 Gy in three or five consecutive daily fractions. The median overall survival time was 1030 days, and the overall mean reduction of the diameter and volume were ~32 and 30% respectively. The endocrine profile normalised in two dogs with cortisol-secreting adrenal tumours. Radio-toxicities were mild and self-limiting. Seven deaths were recorded during the follow-up period and two dogs were censored. CLINICAL SIGNIFICANCE: Hypofractionated stereotactic volumetric-modulated arc radiotherapy should be considered as a feasible and effective therapeutic option for adrenal tumours with vascular invasion.


Asunto(s)
Neoplasias de la Corteza Suprarrenal/veterinaria , Enfermedades de los Perros/radioterapia , Radiocirugia/veterinaria , Neoplasias de la Corteza Suprarrenal/patología , Neoplasias de la Corteza Suprarrenal/radioterapia , Animales , Enfermedades de los Perros/patología , Perros , Estudios de Factibilidad , Femenino , Estudios de Seguimiento , Masculino , Invasividad Neoplásica , Estadificación de Neoplasias/veterinaria , Estudios Prospectivos
3.
Int J Obes Relat Metab Disord ; 22(6): 592-600, 1998 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9665682

RESUMEN

OBJECTIVE: Dieting obese subjects are at risk of developing gallstones. A gallbladder motor dysfunction could have a pathogenetic role. The principal aim of this study was to evaluate the long term effects of two very low calorie diets differing in fat content on gallbladder emptying and gallstone formation in obese subjects. DESIGN AND SUBJECTS: Gallbladder emptying in response to meals (breakfast, lunch and dinner) in two different diet regimens (3.0 vs 12.2 g of fat/d) was evaluated by ultrasonography in 32 gallstone-free obese patients on different days, before and during (at 45 d intervals) one or two 6-month weight reduction diets (for the first three months: 2.24 MJ (535.2 kcal), 3.0 g fat/d vs 2.415 MJ (577.0 kcal), 12.2 g fat/d; for the second three months, the same low calorie diet of 4.194 MJ (1002 kcal)/d for both groups). In 10 subjects, bile analysis was also performed. RESULTS: Twenty-two (69%) subjects concluded the study, eleven in each group, and a significant weight loss was achieved by all subjects. Gallstones (asymptomatic) developed in 6/11 (54.5%) (P < 0.01) of subjects following the lower fat diet, but in none with the higher fat regimen. In the dieters during the first three months (very low calorie phase) the higher fat meals always induced a significantly greater gallbladder emptying than the lower fat meals. The cholesterol saturation index initially increased significantly and then decreased, without difference between the two groups. CONCLUSION: In the obese during rapid weight loss from a very low calorie diet, a relatively high fat intake could prevent gallstone formation, probably by maintaining an adequate gallbladder emptying, which could counterbalance lithogenic mechanisms acting during weight loss.


Asunto(s)
Colelitiasis/etiología , Dieta Reductora/efectos adversos , Grasas de la Dieta/administración & dosificación , Vaciamiento Vesicular , Vesícula Biliar/fisiopatología , Obesidad/dietoterapia , Adolescente , Adulto , Bilis/química , Índice de Masa Corporal , Colelitiasis/prevención & control , Colesterol/análisis , Ingestión de Energía , Femenino , Humanos , Lípidos/análisis , Masculino , Persona de Mediana Edad , Obesidad/complicaciones , Pérdida de Peso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA